ValueAct Capital bought another 2.2 million shares or so of
private equity giant KKR, boosting its stake to 9.9 percent. It
paid between $19.13 and $19.50 per share between November 13
and November 28. At a conference in late April, ValueAct
president Mason Morfit said the stock was worth closer to $37
per share. In an August regulatory filing, ValueAct said it had discussions with
officers and directors of KKR and anticipates holding future
talks about a variety of topics.
In a separate filing, ValueAct said it sold nearly 4
million shares of CBRE, the commercial real estate giant. This
cut its stake to 7.3 percent. The hedge fund firm sold its
shares for between $42.25 and $42 88 per share.
Viking Global Investors said it owns a
little more than 6.6 million shares of Jianpu Technology, or
9.6 percent of the Chinese online financial firm that went
public in mid-November. We earlier reported that Dan
Och’s Och-Ziff Capital Management disclosed it
scooped up 2.5 million shares of Jianpu.
Shares of popular hedge fund stock Micron Technology
continue to tumble, dropping another 3.10 percent on Thursday,
to close at $42.39. The stock is now down nearly 15 percent
this week alone. Still, it is up about 93 percent for the
Shares of Horizon Pharma jumped 4.4 percent, to $14.38,
after UBS raised its price target on the stock from $16 to $20.
At the end of the third quarter, Deerfield Management and Paulson & Co. were among the
company’s top ten shareholders.